Applied DNA Sciences Inc (NASDAQ:APDN)
| 1.18 Delayed Data As of May 24 |  -0.06 / -4.88%Today’s Change | 1.08 Today|||52-Week Range 8.10 | -70.77% Year-to-Date |
Latest APDN News | Press Releases
| Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates May 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.23 |
| Today’s open | 1.24 |
| Day’s range | 1.14 - 1.33 |
| Volume | 70,250 |
| Average volume (3 months) | 75,788 |
| Market cap | $10.5M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | +37.88% |
| Earnings growth (this year) | +31.72% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +367.40% |
| P/E ratio | NM |
| Price/Sales | 4.13 |
| Price/Book | 0.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZSANZosano Pharma Corp | -0.14 | -6.57% |
| KTRAKintara Therapeutics... | -0.01 | -4.85% |
| BLPHBellerophon Therapeu... | -0.02 | -1.55% |
| XBIOXenetic Biosciences ... | -0.01 | -0.95% |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $9.0M |
| Annual profit (last year) | -$14.3M |
| Net profit margin | -158.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stony Brook, New York |
Forecasts
